1.
Nakase T, Guerra GA, Ostrom QT, et al. Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes. Neuro-oncology. 2024. doi:10.1093/neuonc/noae112.
1.
Nakase T, Guerra GA, Ostrom QT, et al. Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes. Neuro-oncology. 2024. doi:10.1093/neuonc/noae112.
1.
Nakase T, Guerra G, Ostrom QT, et al. Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes. medRxiv : the preprint server for health sciences. 2024. doi:10.1101/2024.01.10.24301112.
1.
Rich MB, Zawatsky CLB, Botta JJ, Christensen KD. Public perspective on medications to delay Alzheimer’s disease symptoms. Journal of genetic counseling. 2023. doi:10.1002/jgc4.1708.